Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

FDA Approval Author: John K. Jenkins, M.D., Director, Office of New Drugs, at FDA’s Center for Drug Evaluation and Research Last Updated: Jul 7, 2016 - 5:36:25 PM



Novel New Drug Approvals

By John K. Jenkins, M.D., Director, Office of New Drugs, at FDA’s Center for Drug Evaluation and Research
Jan 30, 2014 - 2:52:42 PM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page

(HealthNewsDigest.com) - Last year marked another strong year for FDA approvals of novel new drugs, known as new molecular entities (NMEs). In 2013, FDA's Center for Drug Evaluation and Research (CDER) approved 27 NMEs last year - about the same as the 26 average NME approvals per year since the beginning of this decade.

More important than the quantity of novel new drugs approved in 2013 is theirquality - and the important new roles many of these drugs can serve in advancing medical care and the health of patients. We now have new safe and effective treatments for a wide range of serious medical conditions, such as late-stage breast cancer, chronic hepatitis C, metastatic melanoma, mantle cell lymphoma, chronic lymphocytic leukemia, homozygous familial hypercholesterolemia, pulmonary arterial hypertension, and many more. Some of these medications offer new hope to patients who previously had few or no treatment options.

Read the entire blog at FDA Voice.

###

For advertising and promotion on HealthNewsDigest.com, call Mike McCurdy: 877-634-9180 or [email protected] We have over 7,000 journalists as subscribers.

 



Top of Page

HealthNewsDigest.com

FDA Approval
Latest Headlines


+ FDA Investigates Findings of Hepatitis A Linked to Frozen Tuna
+ FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia
+ FDA Approves First Cancer Treatment for Any Solid Tumor With a Specific Genetic Feature
+ FDA Approves Drug to Treat ALS
+ FDA Approves Urea Cycle Disorder Treatment for Use in Children as Young as Two Months
+ Novartis Receives FDA Approval for Rydapt® in Newly Diagnosed FLT3-mutated Acute Yeloid Leukemia (AML)
+ FDA Approves New Combination Treatment for Acute Myeloid Leukemia
+ FDA Approves New Drug to Treat Hepatocellular Carcinoma, the Most Common Form of Liver Cancer
+ FDA Expands Approved Use of Stivarga to Treat Liver Cancer
+ FDA Approves First Treatment for Rare Form of Skin Cancer



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions